Department of Medicine, University of Illinois, Chicago, IL, USA.
Liver Transpl. 2012 Apr;18(4):395-404. doi: 10.1002/lt.23398.
Because of the shortage of deceased donor organs, transplant centers accept organs from marginal deceased donors, including older donors. Organ-specific donor risk indices have been developed to predict graft survival with various combinations of donor and recipient characteristics. Here we review the kidney donor risk index (KDRI) and the liver donor risk index (LDRI) and compare and contrast their strengths, limitations, and potential uses. The KDRI has a potential role in developing new kidney allocation algorithms. The LDRI allows a greater appreciation of the importance of donor factors, particularly for hepatitis C virus-positive recipients; as the donor risk index increases, the rates of allograft and patient survival among these recipients decrease disproportionately. The use of livers with high donor risk indices is associated with increased hospital costs that are independent of recipient risk factors, and the transplantation of livers with high donor risk indices into patients with Model for End-Stage Liver Disease scores < 15 is associated with lower allograft survival; the use of the LDRI has limited this practice. Significant regional variations in donor quality, as measured by the LDRI, remain in the United States. We also review other potential indices for liver transplantation, including donor-recipient matching and the retransplant donor risk index. Although substantial progress has been made in developing donor risk indices to objectively assess donor variables that affect transplant outcomes, continued efforts are warranted to improve these indices to enhance organ allocation policies and optimize allograft survival.
由于可供移植的已故器官短缺,移植中心接受来自边缘已故供体的器官,包括年龄较大的供体。已经开发了器官特异性供体风险指数,以预测各种供体和受者特征组合的移植物存活率。在这里,我们回顾了肾脏供体风险指数(KDRI)和肝脏供体风险指数(LDRI),并比较和对比了它们的优缺点及其潜在用途。KDRI 可能在开发新的肾脏分配算法中发挥作用。LDRI 可以更好地认识到供体因素的重要性,特别是对于丙型肝炎病毒阳性受者;随着供体风险指数的增加,这些受者的移植物和患者存活率不成比例地下降。使用高供体风险指数的肝脏与增加的医院成本相关,而与受者风险因素无关,并且将高供体风险指数的肝脏移植到终末期肝病模型评分<15 的患者中与较低的移植物存活率相关;使用 LDRI 限制了这种做法。美国供体质量的显著区域差异,如 LDRI 所衡量的,仍然存在。我们还回顾了其他潜在的肝移植指数,包括供体-受者匹配和再次移植供体风险指数。尽管在开发客观评估影响移植结果的供体变量的供体风险指数方面取得了重大进展,但仍需要继续努力改进这些指数,以加强器官分配政策并优化移植物存活率。